Issue 3/2009

Cytarabine conjugates with biologically active molecules and their potential anticancer activity (177 — 186)

L. NOVOTNY, P. RAUKO

DOI: 10.4149/neo_2009_03_177

Cancer and depression: a prospective study (187 — 193)

L. SLOVACEK, B. SLOVACKOVA, I. SLANSKA, P. PRIESTER, J. PETERA, J. KOPECKY, J. VANASKOVA

DOI: 10.4149/neo_2009_03_187

Isolation and properties of gene-modified mouse bcr-abl-transformed cells expressing various immunostimulatory factors (194 — 201)

M. PETRACKOVA, E. SOBOTKOVA, M. DUSKOVA, P. JINOCH, V. VONKA

DOI: 10.4149/neo_2009_03_194

Imatinib is a substrate for various multidrug resistance proteins (202 — 207)

K. CZYZEWSKI, J. STYCZYNSKI

DOI: 10.4149/neo_2009_03_202

Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells (208 — 214)

J. DURAJ, L. HUNAKOVA, J. BODO, J. JAKUBIKOVA, J. CHOVANCOVA, J. SEDLAK

DOI: 10.4149/neo_2009_03_208

Prognostic factors in patients with relapsed or primary refractory germ cell tumors (215 — 223)

K. REJLEKOVA, M. MEGO, Z. SYCOVA-MILA, J. OBERTOVA, J. RAJEC, T. SALEK, J. MARDIAK

DOI: 10.4149/neo_2009_03_215

Inhibition of cell proliferation and arrest of cell cycle progression by blocking chloride channels in human laryngeal cancer cell line Hep-2 (224 — 229)

W. F. YU, Y. L. ZHAO, K. WANG, M. M. DONG

DOI: 10.4149/neo_2009_03_224

The detection of circulating tumor cells expressing E6/E7 HR-HPV oncogenes in peripheral blood in cervical cancer patients after radical hysterectomy (230 — 238)

P. WEISMANN, E. WEISMANOVA, L. MASAK, K. MLADA, D. KEDER, Z. FERANCIKOVA, M. VIZVARYOVA, M. KONECNY, K. ZAVODNA, J. KAUSITZ, J. BENUSKA, V. REPISKA

DOI: 10.4149/neo_2009_03_230

Expression of p53, cyclin D1 and EGFR correlates with histological grade of adult soft tissue sarcomas: a study on tissue microarrays (239 — 244)

K. VESELY, M. JURAJDA, R. NENUTIL, M. VESELA

DOI: 10.4149/neo_2009_03_239

Epithelial bone marrow cells in patients with advanced esophageal squamous cell carcinoma (245 — 251)

L. USNARSKA-ZUBKIEWICZ, M. STRUTYNSKA-KARPINSKA, M. PODOLAK-DAWIDZIAK, M. NIENARTOWICZ, K. GRABOWSKI, I. PRAJS, K. KULICZKOWSKI

DOI: 10.4149/neo_2009_03_245

Celecoxib and melatonin in prevention of female rat mammary carcinogenesis (252 — 258)

P. ORENDAS, M. KASSAYOVA, K. KAJO, I. AHLERS, P. KUBATKA, B. BOJKOVA, M. PEC, E. AHLERSOVA

DOI: 10.4149/neo_2009_03_252

Autologous Hsp70 immunization induces anti-tumor immunity and increases longevity and survival of tumor-bearing mice (259 — 268)

S. KUMAR, P. DEEPAK, A. ACHARYA

DOI: 10.4149/neo_2009_03_259

Metformin in chemically-induced mammary carcinogenesis in rats (269 — 274)

B. BOJKOVA, P. ORENDAS, M. GARAJOVA, M. KASSAYOVA, V. KUTNA, E. AHLERSOVA, I. AHLERS

DOI: 10.4149/neo_2009_03_269

Genetic analysis of KRAS mutation status in metastatic colorectal cancer patients (275 — 278)

K. ZAVODNA, M. KONECNY, T. KRIVULCIK, S. SPANIK, R. BEHULOVA, M. VIZVARYOVA, E. WEISMANOVA, S. GALBAVY, J. KAUSITZ

DOI: 10.4149/neo_2009_03_275